Novo Integrated Sciences IncNASDAQ:NVOSNASDAQ FSI:H. Deficient and Delinquent (Issuer failed to meet continued listing requirements and missed regulatory filing deadline)
- LAST PRICE0.1267
- TODAY'S CHANGE (%)-0.0082 (-6.0786%)
- Bid / Lots0.1266/ 144
- Ask / Lots0.1267/ 85
- Open / Previous Close0.1370 / 0.1349
- Day Range
- 52 Week Range
- Volume12,227,604
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVOS |
|---|---|---|
| 09:32 ET | 206510 | 0.1341 |
| 09:33 ET | 78529 | 0.1315 |
| 09:35 ET | 25512 | 0.131801 |
| 09:37 ET | 252960 | 0.1328 |
| 09:39 ET | 593644 | 0.129856 |
| 09:42 ET | 244012 | 0.130101 |
| 09:44 ET | 225598 | 0.1295 |
| 09:46 ET | 114194 | 0.1303 |
| 09:48 ET | 182461 | 0.131199 |
| 09:50 ET | 117447 | 0.131001 |
| 09:51 ET | 66635 | 0.130174 |
| 09:53 ET | 241445 | 0.1309 |
| 09:55 ET | 13416 | 0.1309 |
| 09:57 ET | 48525 | 0.1309 |
| 10:00 ET | 40640 | 0.1309 |
| 10:02 ET | 108961 | 0.1308 |
| 10:04 ET | 160368 | 0.1307 |
| 10:06 ET | 90540 | 0.1306 |
| 10:08 ET | 45622 | 0.1305 |
| 10:09 ET | 120212 | 0.1301 |
| 10:11 ET | 283477 | 0.13 |
| 10:13 ET | 50044 | 0.1307 |
| 10:15 ET | 141890 | 0.1299 |
| 10:18 ET | 69809 | 0.1319 |
| 10:20 ET | 205335 | 0.130101 |
| 10:22 ET | 83042 | 0.1302 |
| 10:24 ET | 213746 | 0.1309 |
| 10:26 ET | 56967 | 0.1307 |
| 10:27 ET | 262559 | 0.1295 |
| 10:29 ET | 86821 | 0.1307 |
| 10:31 ET | 160969 | 0.1306 |
| 10:33 ET | 70952 | 0.1306 |
| 10:36 ET | 97542 | 0.13 |
| 10:38 ET | 32042 | 0.1297 |
| 10:40 ET | 21558 | 0.1295 |
| 10:42 ET | 146423 | 0.1291 |
| 10:44 ET | 87948 | 0.128696 |
| 10:45 ET | 93344 | 0.1285 |
| 10:47 ET | 127877 | 0.1279 |
| 10:49 ET | 445673 | 0.126505 |
| 10:51 ET | 1771699 | 0.1255 |
| 10:54 ET | 214315 | 0.126 |
| 10:56 ET | 260240 | 0.1259 |
| 10:58 ET | 304580 | 0.1259 |
| 11:00 ET | 96459 | 0.1269 |
| 11:02 ET | 31824 | 0.1269 |
| 11:03 ET | 164635 | 0.126901 |
| 11:05 ET | 45752 | 0.1268 |
| 11:07 ET | 139498 | 0.1267 |
| 11:09 ET | 192589 | 0.1262 |
| 11:12 ET | 93273 | 0.1269 |
| 11:14 ET | 231097 | 0.1275 |
| 11:16 ET | 78599 | 0.127 |
| 11:18 ET | 32712 | 0.1277 |
| 11:20 ET | 39066 | 0.1278 |
| 11:21 ET | 95682 | 0.1286 |
| 11:23 ET | 90045 | 0.1286 |
| 11:25 ET | 95657 | 0.1278 |
| 11:27 ET | 14603 | 0.1283 |
| 11:30 ET | 50473 | 0.12825 |
| 11:32 ET | 84369 | 0.1276 |
| 11:34 ET | 11482 | 0.1275 |
| 11:36 ET | 168045 | 0.1265 |
| 11:38 ET | 35056 | 0.127351 |
| 11:39 ET | 38999 | 0.12805 |
| 11:41 ET | 98456 | 0.1282 |
| 11:43 ET | 45704 | 0.129 |
| 11:45 ET | 17404 | 0.1282 |
| 11:48 ET | 55706 | 0.1283 |
| 11:50 ET | 13809 | 0.128 |
| 11:52 ET | 41725 | 0.1268 |
| 11:54 ET | 79980 | 0.1267 |
| 11:56 ET | 25255 | 0.126795 |
| 11:57 ET | 96542 | 0.1266 |
| 11:59 ET | 46200 | 0.1266 |
| 12:01 ET | 8747 | 0.1267 |
| 12:03 ET | 69369 | 0.1267 |
Jan 31, 2023
Novo Integrated Sciences Receives Non-Compliance Notice From Nasdaq Over Report Filings, from 3:09AM ET on Tuesday Jan 31, 2023 by MT Newswires
3:09AM ET on Tuesday Jan 31, 2023 by MT Newswires
Jan 30, 2023
BRIEF-Novo Integrated Sciences Announces Receipt Of Notice From Nasdaq, from 4:36PM ET on Monday Jan 30, 2023 by Thomson Reuters
4:36PM ET on Monday Jan 30, 2023 by Thomson ReutersNovo Integrated Sciences Announces Receipt of Notice from Nasdaq, from 4:30PM ET on Monday Jan 30, 2023 by Business Wire
4:30PM ET on Monday Jan 30, 2023 by Business Wire
Jan 24, 2023
Top Premarket Gainers, from 7:46AM ET on Tuesday Jan 24, 2023 by MT Newswires
7:46AM ET on Tuesday Jan 24, 2023 by MT Newswires
Jan 17, 2023
BRIEF-Novo Integrated Sciences Provides Update on Current Actions and Events, from 10:01AM ET on Tuesday Jan 17, 2023 by Thomson Reuters
10:01AM ET on Tuesday Jan 17, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Novo Integrated Sciences Inc | 8.0M | -0.3x | --- |
Concord Medical Services Holdings Ltd | 57.7M | -1.3x | --- |
Aesthetic Medical International Holdings Group Ltd | 48.8M | 0.0x | --- |
Pacific Health Care Organization Inc | 10.8M | 13.1x | +47.63% |
IMAC Holdings Inc | 10.6M | -0.5x | --- |
CarePayment Technologies Inc | 3.2M | -0.1x | --- |
Company Information
Novo Integrated Sciences, Inc. is a parent company to subsidiaries throughout North America. The Company owns Canadian and United States subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy (including pre- and post-partum), acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. The Company's products include ProDip and Terragenx.
Contact Information
- Headquarters
- 11120 NE 2ND STREET, SUITE 100BELLEVUE, WA, United States 98004
- Phone
- 206-617-9797
- Fax
- 386-943-6232
Executives
- Chairman of the Board, Chief Executive Officer
- Robert Mattacchione
- President, Chief Operating Officer, Director
- Christopher David
- Principal Financial Officer
- James Zsebok
- Chief Medical Officer, President of Novomerica Health Group
- Joseph Chalil
- Independent Director
- Arfaraz Ali
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.0M |
|---|---|
Revenue (TTM) | $22.6M |
Shares Outstanding | 59.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.30 |
EPS | $-0.44 |
Book Value | $1.65 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 0.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -29.03% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
